What is the CNTB stock price prediction for next 2 weeks?

According to our price prediction algorithm,Connect Biopharma Holdings Limited (CNTB) price will be around $2.05 in the next 2 weeks. This means it will decrease by -11.31601731601732 from the last closing price. This prediction may vary from other time period filters for CNTB stock.

What can be the highest Possible price of CNTB stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, CNTB can achieve the highest price of $2.24 which is -3.043435568795284 lower than last closing price. This prediction may vary from other time period filters for CNTB stock.

What can be the lowest Possible price of CNTB stock in next 2 weeks?

As per the forecast and algorithmic analysis, CNTB stock price can be as low as $1.86 which is -19.534274541697286 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for CNTB stock.

Will CNTB stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that CNTB stock will lose-11.31601731601732 in the next 2 weeks. This prediction may vary from other time period filters for CNTB stock.

What is CNTB stock last closing price?

Last closing price of CNTB stock was $2.31.

What is CNTB stock price prediction?

CNTB stock price prediction means predicting the future closing prices of CNTB stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CNTB stock in a certain time period.

How we predict CNTB stock future prices?

If you are searching for CNTB stock forecast, analysis or price prediction, then you might be wondering what Connect Biopharma Holdings Limited (CNTB) will do in the future. Our CNTB price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CNTB price prediction will likely answer most of your questions.

How frequent we update CNTB stock predictions?

We are updating the forecasts for the CNTB stock on daily basis.

Is using ML forecasting for CNTB stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for CNTB stock same for all the time periods?

No, the prediction for CNTB stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Connect Biopharma Holdings Limited Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$2.31-0.86%Since 2 Weeks

Predicted Price$2.05-11.32%For 2 Weeks

Upper Predicted Price$2.24-3.04%For 2 Weeks

Lower Predicted Price$1.86-19.53%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of CNTB will decline by -11.32% over the next 2 Weeks and hit $2.05 by Wednesday, June 3, 2026. In that time frame, CNTB's share price is expected to range between $1.86 and $2.24.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jun 3, 2026	1.86	2.05	2.24
Jun 2, 2026	1.92	2.10	2.28
Jun 1, 2026	1.92	2.11	2.30
May 29, 2026	2.09	2.27	2.46
May 28, 2026	2.00	2.19	2.37
May 27, 2026	1.96	2.14	2.32
May 26, 2026	2.01	2.19	2.38
May 25, 2026	2.02	2.20	2.37
May 22, 2026	2.17	2.36	2.54
May 21, 2026	2.10	2.28	2.46

CNTB shares rose +2.60% in Thursday, May 21, 2026's trading session, rising from a previous close of $2.31 to move at $2.37. The stock demonstrated notable intraday movement (see CNTB's key stats for a full breakdown), fluctuating between $2.28 and $2.40, a +5.26% trading range. While recent weeks have seen some volatility, CNTB has managed to secure a +1.72% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 201.29K shares changing hands, 71.38K more than the previous session. This amounted to $477.06K in total market activity.

Will CNTB Continue Its Downward Trend?

According to analyst ratings and projections for CNTB, Connect Biopharma Holdings Limited shares are anticipated to decrease by -5.82%, potentially reaching $2.24 per share by June 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for CNTB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the CNTB stock forecast, now is not the best time to buy CNTB stock because its current trading price is +15.69% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CNTB covering social and institutional perspectives.

CNTB Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CNTB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 46.02% to 47.35%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 48.73%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.51%, maintains a neutral outlook for the long term. Insights into CNTB's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Connect Biopharma Short-Term Forecasts

CNTB Forecast For Next 5 Days

Our algorithm anticipates Connect Biopharma (CNTB) stock could hit $1.99 by May 28, 2026. This represents a -15.93% rise from today's price, following a +8.49% change over the past five days.

CNTB Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Connect Biopharma Holdings Limited (CNTB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.21, which would mean a -6.75% decrease from the current price of $2.37. Projections for this period range from a high of $2.63 to a low of $1.72.

CNTB Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Connect Biopharma's price over the next three months point to a rise. CNTB stock is expected to peak at $15.61 on May 22, 2026 before potentially dipping to $6.08 on Aug 20, 2026. On average, CNTB is likely to trade around $9.54 in the coming 90 days.

Connect Biopharma Stock Forecast 2025

Based on our predictive models, Connect Biopharma (CNTB) is expected to trade between $4.86 and $15.61 throughout 2026. This would result in an average price of $9.04, potentially offering investors a +281.43% return from current levels.

Connect Biopharma Holdings Limited Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Connect Biopharma Holdings Limited (CNTB) is positioned to show a strong performance in May 2026. The price is predicted to move between $14.02 and $15.61, settling at an average of $14.85. This could translate to a +526.58% gain.

June 2026

Based on current market signals, Connect Biopharma Holdings Limited is projected to trend june 2026. We forecast a trading range from $8.65 to $13.32, with a likely average price of $10.71. Investors could expect a potential return of +351.90%.

July 2026

Our predictive algorithms indicate Connect Biopharma Holdings Limited stock may see a shift in July 2026. The expected range spans $6.98–$9.17, with an average target of $8.20. This represents a positive outlook and a possible gain of +245.99%.

August 2026

Analyzing established trends, Connect Biopharma Holdings Limited looks set to move in August 2026. Projections place the stock between $5.00 and $9.14, averaging around $6.90. This suggests a +191.14% gain from current levels.

September 2026

Market indicators suggest Connect Biopharma Holdings Limited could experience notable changes during September 2026. Prices could fluctuate within $4.86 to $9.72, with a midpoint forecast of $7.30. The stock might deliver a +208.02% gain.

October 2026

Forecasting for October 2026, models estimate that Connect Biopharma Holdings Limited may undergo key fluctuations. If trends hold, the stock might trade between $7.70 and $11.30, averaging $9.44. This signals a positive trajectory with potential returns around +298.31%.

November 2026

According to our latest forecast models, Connect Biopharma Holdings Limited (CNTB) is positioned to show a strong performance in November 2026. The price is predicted to move between $6.24 and $13.04, settling at an average of $10.05. This could translate to a +324.05% gain.

December 2026

Based on current market signals, Connect Biopharma Holdings Limited is projected to trend december 2026. We forecast a trading range from $6.45 to $12.27, with a likely average price of $8.85. Investors could expect a potential return of +273.42%.

January 2027

Our predictive algorithms indicate Connect Biopharma Holdings Limited stock may see a shift in January 2027. The expected range spans $6.48–$12.59, with an average target of $9.51. This represents a positive outlook and a possible gain of +301.27%.

February 2027

Analyzing established trends, Connect Biopharma Holdings Limited looks set to move in February 2027. Projections place the stock between $6.75 and $19.44, averaging around $13.18. This suggests a +456.12% gain from current levels.

March 2027

Market indicators suggest Connect Biopharma Holdings Limited could experience notable changes during March 2027. Prices could fluctuate within $9.06 to $21.58, with a midpoint forecast of $15.11. The stock might deliver a +537.55% gain.

April 2027

Forecasting for April 2027, models estimate that Connect Biopharma Holdings Limited may undergo key fluctuations. If trends hold, the stock might trade between $5.08 and $21.25, averaging $12.64. This signals a positive trajectory with potential returns around +433.33%.

May 2027

According to our latest forecast models, Connect Biopharma Holdings Limited (CNTB) is positioned to show a strong performance in May 2027. The price is predicted to move between $4.66 and $16.13, settling at an average of $10.01. This could translate to a +322.36% gain.

CNTB's history of dividends and stock splits also plays a role in long-term investor confidence.